Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice

Fig. 2

Prolonged Dasatinib treatment improves diastolic function in db/db mice. (A) Cartoon of the experimental protocol. (B) Body weight values during the follow-up. (C) Heart rate during echocardiography assessment. (D-M) Bar graphs showing the data of echocardiography regarding LV volume in systole (s) before and after correction for the LV mass (D & E), LV volume in diastole (d) before and after correction for the LV mass (F & G), LV mass (H), ejection fraction (I), cardiac output (J), cardiac index (K), E/A ratio (L), and NFT (M). Bar graphs show individual values and means ± SEM. n = 4 to 9 animals per group

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840